Al Hammadi says acquisition of 35% of Sudair Pharma approved by GAC

11/10/2021 Argaam

Al Hammadi Company for Development and Investment said the General Authority for Competition (GAC) approved its acquisition of a 35% stake in Sudair Pharmaceutical Co. (SPC).

 

Al Hammadi will finalize the acquisition’s necessary paperwork and announce the deal completion in a timely manner, the healthcare service provider added in a statement to Tadawul.

 

Last July, the Tadawul-listed company signed an agreement to acquire Gulf Investment Corporation’s (GIC) 35% stake in Sudair Pharmaceutical, Argaam earlier reported.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.